R&D News | pharmaphorum

News

Biotech association steps in to fight growth of ‘plausibilit...

The UK’s Supreme Court is to allow the UK BioIndustry Association (BIA) to intervene in a long-running legal battle over a drug patent.

News

NICE must be reformed - Janssen UK market access chief

Janssen’s UK pricing chief Jennifer Lee has called for reform of NICE following the company’s successful but drawn-out attempt to get its cancer drug Darzalex to NHS patients.

M&A

After losing out on two big deals, Sanofi to buy Bioverativ ...

French pharma makes move into haemophilia market.

News

MSD attracts top British scientist to head up UK discovery c...

Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.

News

Biocon and Sandoz strike biosimilars partnership

Companies will develop and market several biosimilars

News

NICE backs interim funding for Janssen cancer drug

NICE has recommended that Janssen’s Darzalex (daratumumab) should be reimbursed on an interim basis by the Cancer Drugs Fund in pre-treated multiple myeloma, after months of wrangling.

Biotech association steps in to fight growth of ‘plausibilit...

NICE must be reformed - Janssen UK market access chief

After losing out on two big deals, Sanofi to buy Bioverativ ...

MSD attracts top British scientist to head up UK discovery c...

Biocon and Sandoz strike biosimilars partnership

NICE backs interim funding for Janssen cancer drug

BMS shakes up R&D under CMO Cristian Massacesi

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks